Generic Medicine Info
Hypersensitivity to nitrofurans; impaired renal function; infants <3 mth; G6PD deficiency; porphyria; pregnancy.
Special Precautions
Elderly; preexisting pulmonary, hepatic, neurological dysfunction; conditions which may predispose to peripheral neuropathy (anaemia; DM; electrolyte imbalance; vit B and folate deficiency), lactation.
Adverse Reactions
GI effects; neurological effects; severe, sometimes irreversible peripheral polyneuropathy; hypersensitivity reactions; acute pulmonary sensitivity; subacute or chronic pulmonary symptoms; hepatotoxicity; blood disorders; brownish discolouration of urine.
Drug Interactions
Quinolone antibacterials may antagonise effects; antibacterial effects may be decreased by carbonic anhydrase inhibitors and drugs that alkalinise the urine. Probenecid or sulfinpyrazone may reduce excretion of nifurtoinol; magnesium trisilicate may reduce absorption. May reduce the effects of oral contraceptives.
CIMS Class
ATC Classification
J01XE02 - nifurtoinol ; Belongs to the class of nitrofuran derivative antibacterials. Used in the systemic treatment of infections.
Disclaimer: This information is independently developed by CIMS based on nifurtoinol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in